Eyer Florian, Felgenhauer Norbert, Pfab Rudolf, Drasch Gustav, Zilker Thomas
Department of Toxicology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.
Clin Toxicol (Phila). 2006;44(4):395-7. doi: 10.1080/15563650600671795.
Intravenous injection of elemental mercury (Hg) is rare and considered relatively harmless. Treatment recommendations vary and the effectiveness of chelation therapy is controversial.
A 27-year-old man intravenously injected 1.5 mL of elemental Hg. Within 12 hours he became febrile, tachycardic and dyspneic. Physical examination was unremarkable. X-rays showed scattered radiodense deposits in the lung, heart, intestinal wall, liver and kidney. The serum Hg level on admission was 172 microg/L and peaked on day 6 at 274 microg/L. Cumulative renal elimination during a five day oral treatment period with 2,3-dimercaptopropane-1-sulfonate (DMPS) and meso-2,3-dimercaptosuccinic acid (DMSA) was 8 mg and 3 mg, respectively.
Although urinary excretion could be enhanced during chelation therapy, Hg deposits in organs resulted in negligible elimination of mercury compared to the exposed dose.
静脉注射元素汞(Hg)的情况罕见,且被认为相对无害。治疗建议各不相同,螯合疗法的有效性存在争议。
一名27岁男性静脉注射了1.5毫升元素汞。12小时内,他出现发热、心动过速和呼吸困难。体格检查无异常。X线显示肺、心脏、肠壁、肝脏和肾脏有散在的高密度沉积物。入院时血清汞水平为172微克/升,第6天达到峰值274微克/升。在使用2,3-二巯基丙烷-1-磺酸钠(DMPS)和内消旋-2,3-二巯基琥珀酸(DMSA)进行为期五天的口服治疗期间,肾脏的累积排泄量分别为8毫克和3毫克。
尽管螯合治疗期间可增强尿排泄,但与暴露剂量相比,器官中的汞沉积物导致汞的消除量可忽略不计。